639820-27-2

Upstream product

• 639820-25-0 3-O-allyl-2-N-(benzyloxycarbonyl)amino-5-O-(tert-butyldiphenylsilyl)-2-deoxy-D-xylono-1,4-lactone 
• 639820-22-7 (S)-5-((tert-butyldiphenylsilyloxy)methyl)-2-oxo-2,5-dihydrofuran-3-yl trifluoromethanesulfonate 
• 5336-08-3 D-Ribono-1,4-lactone 
• 92512-33-9 (3R,4S,5R)-5-((tert-butyldiphenylsilyloxy)methyl)-3,4-dihydroxydihydrofuran-2(3H)-one 
• 639820-26-1 2-N-(benzyloxycarbonyl)amino-5-O-(tert-butyldiphenylsilyl)-2-deoxy-D-xylono-1,4-lactone 
• 639820-23-8 (1R,4S,5S)-4-[(tert-butyldiphenylsilyloxy)methyl]-6-(3',4'-dimethoxybenzyl)-3-oxa-6-azabicyclo[3.1.0]hexan-2-one 
• 639820-24-9 (1R,4S,5S)-6-(benzyloxycarbonyl)-4-[(tert-butyldiphenylsilyloxy)methyl]-3-oxa-6-azabicyclo[3.1.0]hexan-2-one 

Relevant academic research and scientific papers

Enantiospecific Total Synthesis of (-)-Polyoxamic Acid Using 2,3-Aziridino-γ-lactone Methodology

The non-natural enantiomer of polyoxamic acid was synthesized in six steps from 2,3-aziridino-γ-lactone 7 with an overall yield of 10%. The key step of the strategy is a deprotection-protection sequence on the nitrogen atom of the aziridine ring required